Literature DB >> 26719217

Cyclin-Dependent Kinases as Coregulators of Inflammatory Gene Expression.

M Lienhard Schmitz1, Michael Kracht2.   

Abstract

Cyclin-dependent kinases (CDKs) exert a variety of functions through regulation of the cell cycle and gene expression, thus implicating them in diverse biological processes. Recent studies have deciphered the molecular mechanisms employed by nuclear CDKs to support the expression of inflammatory mediators. Induced transcription of many proinflammatory genes is increased during the G1 phase of the cell cycle in a CDK-dependent manner. This process involves the cytokine-induced recruitment of CDK6 to the nuclear chromatin fraction where it associates with transcription factors of the NF-κB, STAT, and AP-1 families. The ability of CDK6 to trigger the expression of VEGF-A and p16(INK4A) and to recruit the NF-κB subunit p65 to its target sites is largely independent of its kinase function. The involvement of CDKs in proinflammatory gene expression also allows therapeutic targeting of their functions to interfere with tumor-promoting inflammation or chronic inflammatory diseases.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  NF-κB; cancer; cell cycle; cyclin-dependent kinases; inflammation

Mesh:

Substances:

Year:  2015        PMID: 26719217     DOI: 10.1016/j.tips.2015.10.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

1.  CDK4/6 inhibitor palbociclib suppresses IgE-mediated mast cell activation.

Authors:  Yi-Bo Hou; Kunmei Ji; Yue-Tong Sun; Li-Na Zhang; Jia-Jie Chen
Journal:  J Transl Med       Date:  2019-08-20       Impact factor: 5.531

2.  Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.

Authors:  Yun Liang; Xianying Xing; Maria A Beamer; William R Swindell; Mrinal K Sarkar; Liza Wolterink Roberts; John J Voorhees; J Michelle Kahlenberg; Paul W Harms; Andrew Johnston; Johann E Gudjonsson
Journal:  J Allergy Clin Immunol       Date:  2016-11-21       Impact factor: 10.793

3.  Cyclin-dependent kinase activity is required for type I interferon production.

Authors:  Oya Cingöz; Stephen P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

4.  Cellular Senescence Biomarker p16INK4a+ Cell Burden in Thigh Adipose is Associated With Poor Physical Function in Older Women.

Authors:  Jamie N Justice; Heather Gregory; Tamar Tchkonia; Nathan K LeBrasseur; James L Kirkland; Stephen B Kritchevsky; Barbara J Nicklas
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

5.  CDK4/6 inhibitor palbociclib reduces inflammation in lupus-prone mice.

Authors:  Yongfeng Zhang; Ben Jin; Haiyan D Miller; Dongxia Ge; Xin Zhang; Zongbing You
Journal:  Am J Clin Exp Urol       Date:  2021-02-15

Review 6.  Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.

Authors:  Mitra Zabihi; Ramin Lotfi; Amir-Mohammad Yousefi; Davood Bashash
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-04       Impact factor: 4.553

7.  Metabolomic Analysis Reveals that SPHK1 Promotes Oral Squamous Cell Carcinoma Progression through NF-κB Activation.

Authors:  Chen-Xing Hou; Guang-Yan Mao; Qiu-Wangyue Sun; Ying Meng; Qing-Hai Zhu; Yu-Ting Tang; Wei Han; Nan-Nan Sun; Xiao-Meng Song; Chen-Xing Wang; Jin-Hai Ye
Journal:  Ann Surg Oncol       Date:  2022-07-12       Impact factor: 4.339

8.  CDK14 involvement in proliferation migration and invasion of esophageal cancer.

Authors:  Lingling Chen; Yayun Wang; Wenyan Jiang; Runzhou Ni; Yuchan Wang; Sujie Ni
Journal:  Ann Transl Med       Date:  2019-11

9.  Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment.

Authors:  Tony Eight Lin; Chia-Ron Yang; Ching-Hsuan Chou; Jui-Yi Hsu; Min-Wu Chao; Tzu-Ying Sung; Jui-Hua Hsieh; Wei-Jan Huang; Kai-Cheng Hsu
Journal:  Biomed Pharmacother       Date:  2021-12-22       Impact factor: 6.529

10.  Genetic Ablation of p16INK4a Does Not Protect against Cellular Senescence in Mouse Models of Chronic Obstructive Pulmonary Disease/Emphysema.

Authors:  Isaac K Sundar; Kahkashan Rashid; Janice Gerloff; Dongmei Li; Irfan Rahman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-08       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.